跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXMEDETOMIDINA HIKMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DEXMEDETOMIDINA HIKMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Approved
STANDARD
DEXMEDETOMIDINA HIKMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Hikma Farmaceutica (Portugal) S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 27, 2024
Approval ID
d2121b39cf03cb41
Company
Hikma Farmaceutica (Portugal) S.A.
Type
Standard
Approval Details
Approval Id
d2121b39cf03cb41
Drug Cima Aemps Name
DEXMEDETOMIDINA HIKMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Register Number
89593
Holder Company Name
Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name
Hikma España, S.L.U.
Holder Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Authorization Date
2024-05-27
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 microgramos/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Hikma Farmaceutica (Portugal) S.A.
Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Company Information
Pharmaceutical Company Name
HIKMA FARMACÊUTICA (PORTUGAL), S.A.
Country Name
Portugal
City Name
terrugem snt,lisboa,country_pt
Address
ESTRADA RIO DA MÓ, 8/8A/B
Active Ingredients
DEXMEDETOMIDINA HIDROCLORURO
118,2 microgramos/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 27, 2024
Approval ID
d2121b39cf03cb41
Type
Standard
Back to CIMA-AEMPS Approvals